Many health and wellness stocks have faced challenges in recent years as GLP-1 weight-loss drugs like Ozempic and Wegovy ...

WeightWatchers’ stock was surging after the company emerged from bankruptcy two months after it was announced.

EXCLUSIVE: Top doctor Dr Kim Boyd says its programmes are needed 'more than ever' despite the boom in weight loss drugs.

An iconic weight-loss company has emerged from several months of bankruptcy with a revamped business strategy.

WW International relists on Nasdaq, pivoting to menopause care with GLP-1 drugs and coaching. Click here to read an analysis ...

Weight Watchers went bankrupt in May, but now it promises it's trimmed the fat off its books and is ready to rejoin the ...

With new leadership and a Nasdaq relisting plan, the iconic brand is betting on women’s health and weight loss drugs to stage ...

WeightWatchers on Tuesday named Dr. Kim Boyd as chief medical officer and said it was planning a new program to help women ...

WW International , formerly known as WeightWatchers, is on track to exit its financial reorganization to cut $1.15 billion in debt next week as part of its bankruptcy process, the weight management ...